Dr. Ryota Sato, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1301 Punchbowl St, Honolulu, HI 96813 Phone: 808-691-1000 |
News Archive
New genetic testing has been developed at the University of Oxford to detect early signs of a potentially fatal condition that can also develop into full blown leukaemia in children with Down's syndrome.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
Robots that could take on basic healthcare tasks to support the work of doctors and nurses may be the way of the future. Who knows, maybe a medical robot can prescribe your medicine someday? That's the idea behind 3D structural-sensing robots being developed and tested at Simon Fraser University by Woo Soo Kim, associate professor in the School of Mechatronic Systems Engineering.
A team led by scientists at The Scripps Research Institute has solved the structure of one of the receptors that responds to the neurotransmitter dopamine. Although dopamine transmission is essential to normal brain functioning, the biological assembly of the molecules involved in this crucial neuronal interplay had not been known until now.
Researchers at the George Washington University, led by Michael S. Irwig, M.D., found that men referred for tertiary care for borderline testosterone levels had much higher rates of depression and depressive symptoms than those of the general population.
› Verified 2 days ago